NEOG vs BFLY vs CV Stock Comparison

Neogen, Butterfly Network and CapsoVision Prices as of Nov 2, 2026 Peers: Industry group
1 more company in this comparison (GEHC) Create a free account to keep reading and compare up to 10 companies.
NEOG Neogen Corp
$11.82 -2.7% 1M +91.6% 1Y
Market cap
$2.74B
P/E
–
Revenue (TTM)
$883.99M
Div. yield
–
Diagnostic Equipment Healthcare
4 wins
BFLY Butterfly Network, Inc.
$6.14 -31.2% 1M +128.3% 1Y
Market cap
$1.75B
P/E
–
Revenue (TTM)
$123.25M
Div. yield
–
Diagnostic Equipment Healthcare
3 wins
CV CapsoVision, Inc
$6.73 +9.1% 1M +37.9% 1Y
Market cap
$350.56M
P/E
–
Revenue (TTM)
$14.41M
Div. yield
–
Diagnostic Equipment Healthcare

Head to Head

7 decided of 12

Neogen leads on 4 of the 12 questions below (Neogen 4, Butterfly Network 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionNEOGBFLYCVLeader
Larger companyMarket capitalisation $2.74B $1.75B $350.56M NEOG
Cheaper on earningsLower P/E, profitable companies only -48.8x -32.6x -12.8x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 37.8x — — –
Faster revenue growthRevenue growth, trailing twelve months -0.3% +39.4% +14.6% BFLY
More profitableNet margin, trailing twelve months -6.3% -43.6% -190.2% NEOG
Better return on capitalReturn on invested capital -0.2% — — –
Less leveragedLower net debt / EBITDA 5.4x — — –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months +91.6% +128.3% +37.9% BFLY
Better 5-year returnAnnualised price return, 5 years -23.1%/yr -10.4%/yr — BFLY
Less volatileAnnualised volatility, 1 year 55.7% 112.8% 96.2% NEOG
Higher overall scoreMean of the five percentile scores vs peers 58/100 49/100 37/100 NEOG

Percentile Scorecard

NEOGBFLYCV

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisNEOGBFLYCV
Valuation 72 #65 of 227 31 #158 of 227 5 #216 of 227
Growth 49 #112 of 220 87 #29 of 220 43 #126 of 220
Profitability 62 #80 of 209 39 #128 of 209 23 #161 of 209
Financial Health 48 #126 of 240 57 #105 of 240 77 #57 of 240
Shareholder Returns 58 #59 of 138 30 #97 of 138 –
Overall 58 49 37
  • NEOG ranked among 247 companies in Medical Devices and Diagnostics
  • BFLY ranked among 247 companies in Medical Devices and Diagnostics
  • CV ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodNEOGBFLYCVSPY
1 month -2.7%-31.2%+9.1% -2.3%
3 months -0.7%-25.2%-6.1% -0.7%
6 months +30.0%+26.6%-4.8% +4.8%
Year to date +69.1%+61.6%-37.0% +10.3%
1 year +91.6%+128.3%+37.9% +10.3%
3 years -25.3%+448.2%— +73.0%
3 years, per year -9.3%+76.4%— +20.1%
5 years -73.0%-42.3%— +61.9%
5 years, per year -23.1%-10.4%— +10.1%
10 years -39.4%—— +258.6%
10 years, per year -4.9%—— +13.6%

Risk

MeasureNEOGBFLYCVSPY
Volatility, 1Y 55.7%112.8%96.2% 12.8%
Downside volatility, 1Y 46.7%94.2%89.3% 12.8%
Beta vs S&P 500, 1Y 1.433.090.64 1.00
Return / volatility, 1Y 1.641.140.39 0.80
Max drawdown, 5Y -90.6%-93.4%-67.8% -25.4%
From 52-week high -15.5%-38.2%-53.3% -3.5%
52-week high $13.98$9.94$14.42 $779.14
52-week low $5.41$1.97$4.59 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleNEOGBFLYCV
P/E now vs peer median -46.0xmedian 28.4x -30.0xmedian 28.4x -12.3xmedian 28.4x
P/S now vs peer median 2.9xmedian 3.0x 11.9xmedian 3.0x 23.4xmedian 3.0x
EV/EBITDA now vs peer median 28.7xmedian 18.0x -26.3xmedian 18.0x -12.2xmedian 18.0x
P/FCF now vs peer median 51.8xmedian 25.0x -53.0xmedian 25.0x —median 25.0x
P/B now vs peer median 1.2xmedian 2.3x 7.9xmedian 2.3x 25.6xmedian 2.3x
PEG now vs peer median 1.64median 0.93 -1.00median 0.93 —median 0.93

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsNEOGBFLYCV
Revenue $883.99M $123.25M $14.41M
Gross profit $418.98M $86.60M $7.55M
Operating income -$7.38M -$57.83M -$27.71M
Net income -$56.10M -$53.69M -$27.42M
Free cash flow $49.80M -$27.55M –
R&D $19.76M $39.57M $20.51M
EPS (diluted) $-0.26 $-0.20 $-0.55
Cash & equivalents $172.00M $122.30M –
Total debt $774.20M – –
Shares (diluted) 218.10M 262.10M 49.94M
Enterprise value $2.08B $1.21B $350.56M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricNEOGBFLYCV
P/E -46.0x -30.0x -12.3x
P/FCF 51.8x -53.0x –
P/Operating cash flow 30.3x -62.5x –
P/S 2.9x 11.9x 23.4x
P/B 1.2x 7.9x 25.6x
P/Tangible book 3.3x 8.2x 25.6x
EV/EBITDA 28.7x -26.3x -12.2x
EV/EBIT -431.4x -23.2x -12.1x
EV/Revenue 3.6x 10.9x 23.4x
EV/FCF 63.9x -48.6x –
EV/Operating cash flow 37.3x -57.2x –
PEG (3Y EPS CAGR) 1.64 -1.00 –

Growth

14 metrics
MetricNEOGBFLYCV
Revenue growth (1Y) -0.3% 39.4% 14.6%
Revenue CAGR (3Y) -1.3% 21.7% –
Gross profit growth (1Y) 1.8% 126.4% 11.1%
Gross profit CAGR (3Y) -3.1% 30.5% –
Operating income growth (1Y) 99.3% 33.5% -36.1%
Operating income CAGR (3Y) -29.0% 26.9% –
Net income growth (1Y) 94.6% 32.8% -34.9%
Net income CAGR (3Y) -28.3% 24.2% –
EPS growth (1Y) 94.6% 35.4% 93.8%
EPS CAGR (3Y) -28.0% 30.0% –
Operating cash flow growth (1Y) -1.9% 5.8% –
Operating cash flow CAGR (3Y) 2.9% 41.1% –
Free cash flow growth (1Y) 1,631% -0.1% –
Free cash flow CAGR (3Y) 126.1% 38.8% –

Profitability

14 metrics
MetricNEOGBFLYCV
Gross margin 47.4% 70.3% 52.4%
EBITDA margin 12.5% -41.4% -190.7%
Operating margin -0.8% -46.9% -192.3%
Pretax margin -7.7% -43.5% -190.1%
Net margin -6.3% -43.6% -190.2%
FCF margin 5.6% -22.4% –
Operating cash flow margin 9.6% -19.0% –
Return on equity -2.7% -28.7% -207.5%
Return on assets -1.7% -18.8% -149.3%
Return on invested capital -0.2% – –
Return on capital employed -0.2% -26.6% -209.8%
Asset turnover 0.3x 0.4x 0.8x
Cash conversion (OCF / net income) -1.5x 0.4x –
Stock comp / revenue 1.3% 20.8% –

Financial Health

11 metrics
MetricNEOGBFLYCV
Debt / assets 23.4% – –
Debt / equity 0.4x – –
Net debt / EBITDA 5.4x – –
Debt / FCF 15.5x – –
Liabilities / assets 36.8% 36.0% 29.1%
Equity / assets 63.2% 64.0% 70.9%
Interest coverage – -46.8x –
Current ratio 3.9x 3.6x 3.4x
Quick ratio 2.1x 2.3x –
Cash ratio 1.2x 1.8x –
Altman Z-score 1.45 4.51 21.20

Shareholder Returns

7 metrics
MetricNEOGBFLYCV
Dividend yield – – –
Net buyback yield -0.1% -0.6% –
Shareholder yield -0.1% -0.6% 0.0%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusNEOGBFLYCV
Forward P/E 37.8xFY2026 – –
EPS, next fiscal year $0.32FY2026 $-0.10FY2026 $-0.58FY2026
EPS growth, next FY 0.0%FY2026 – –
EPS growth, the year after +31.3% – –
Revenue, next fiscal year $847.28MFY2026 $114.50MFY2026 $13.91MFY2026
Revenue growth, next FY -2.7%FY2026 +17.3%FY2026 +2.7%FY2026
Revenue growth, the year after -1.5% +26.0% +46.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersNEOGBFLYCV
Held by institutions 100.0% 59.9% 10.2%
Institutions holding 315 247 50
Change in shares held, QoQ +1.6% +13.9% +27.6%
Institutions buying 151 143 36
Institutions selling 106 59 8
Buyers to sellers 1.42 2.42 4.50

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

NEOGBFLYCV
NEOG 1.00 0.24 0.04
BFLY 0.24 1.00 0.06
CV 0.04 0.06 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, NEOG, BFLY and CV?

Neogen (NEOG) is the largest by market capitalisation: Neogen (NEOG) $2.74B, Butterfly Network (BFLY) $1.75B, CapsoVision (CV) $350.56M.

Which company is growing faster?

Butterfly Network (BFLY) grew revenue fastest over the trailing twelve months: Neogen (NEOG) -0.3%, Butterfly Network (BFLY) +39.4%, CapsoVision (CV) +14.6%.

Which company is more profitable?

Neogen (NEOG) has the highest net margin (Neogen (NEOG) -6.3%, Butterfly Network (BFLY) -43.6%, CapsoVision (CV) -190.2%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Neogen (NEOG) +91.6%, Butterfly Network (BFLY) +128.3%, CapsoVision (CV) +37.9%. Over five years, Butterfly Network (BFLY) compounded fastest (Neogen (NEOG) -23.1%/yr, Butterfly Network (BFLY) -10.4%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Neogen (NEOG) has been the steadiest (Neogen (NEOG) 55.7%, Butterfly Network (BFLY) 112.8%, CapsoVision (CV) 96.2%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, NEOG, BFLY and CV?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Neogen (NEOG) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.